The State Drug Administration approves the listing of 1 innovative drug, Ben Vimod cream, for the treatment of mild to moderate stability common psoriasis in adults
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
today, the State Drug Administration announced that the recent approval of a class of new(http:// through the priority review and approval process,Ben Vimod emulsion, for local treatment of adult light to moderate stability common psoriasisIt is understood that Benvimode is a tyrosine protein kinase inhibitor, can inhibit T-cell tyrosine protein kinase, interference / blocking cytokines and inflammatory media release, T-cell migration and skin cell activation, etcthe's launch of benvimod lactate cream will provide a newdrug(http://) treatment for patients with mild to moderate stability of patients with common psoriasis
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
